PMAQX
Price
$48.46
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
VKSCX
Price
$20.01
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

PMAQX vs VKSCX

Header iconPMAQX vs VKSCX Comparison
Open Charts PMAQX vs VKSCXBanner chart's image
Principal MidCap R6
Price$48.46
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Virtus KAR Small-Mid Cap Core C
Price$20.01
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
PMAQX vs VKSCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PMAQX vs. VKSCX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMAQX is a Buy and VKSCX is a Buy.

FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 29.8B vs. VKSCX (2.26B). PMAQX pays higher dividends than VKSCX: PMAQX (0.10) vs VKSCX (0.00). PMAQX was incepted earlier than VKSCX: PMAQX (8 years) vs VKSCX (7 years). VKSCX is a more actively managed with annual turnover of: 18.00 vs. PMAQX (10.10). PMAQX has a lower initial minimum investment than VKSCX: PMAQX (0) vs VKSCX (2500). PMAQX annual gain was more profitable for investors over the last year : 32.12 vs. VKSCX (25.77). VKSCX return over 5 years is better than : 66.47 vs. PMAQX (55.10).
PMAQXVKSCXPMAQX / VKSCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years7 years-
Gain YTD26.39513.500196%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets29.8B2.26B1,317%
Annual Yield % from dividends0.100.00-
Returns for 1 year32.1225.77125%
Returns for 3 years6.882.14321%
Returns for 5 years55.1066.4783%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LIXT1.65-0.03
-1.79%
Lixte Biotechnology Holdings
ATRO16.49-0.38
-2.25%
Astronics Corp
LFST7.22-0.18
-2.43%
LifeStance Health Group
CVNA239.98-6.77
-2.74%
Carvana Co
IPSC1.33-0.08
-5.67%
Century Therapeutics